doctors now have access to an alternative oral therapy – the first new oral option for more than 20 years. Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and related product ...
Eli Lilly and Boehringer Ingelheim's blockbuster diabetes drug Jardiance (empagliflozin) has been granted approval by the US Food and Drug Administration (FDA) for a wider range of heart failure ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback